Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20801672 | 0.67 | SLC6A4 (0.32) | — | |
| SCHEMBL6737364 | 0.66 | — | — | |
| SCHEMBL4546380 | 0.66 | — | — | |
| SCHEMBL20885618 | 0.65 | ALDH1A1 (0.30) | — | |
| SCHEMBL19590679 | 0.64 | — | — | |
| SCHEMBL20375529 | 0.64 | — | — | |
| SCHEMBL19433764 | 0.64 | — | — | |
| SCHEMBL20801673 | 0.62 | — | — | |
| SCHEMBL19433759 | 0.61 | AOC3 (0.32) | AOC3 | |
| SCHEMBL19434105 | 0.60 | AOC3 (0.42) | AOC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11570992-B2 | Bicyclic compounds | BASF SE (DE) | 2023-02-07 | — | — | US | disclosed |
| US-20190104738-A1 | BICYCLIC COMPOUNDS | BASF CHEMICALS INDIA PVT. LTD. (IN) | 2019-04-11 | — | — | US | disclosed |
| EP-3453706-A1 | PESTICIDAL IMIDAZOLE COMPOUNDS | BASF SE (DE) | 2019-03-13 | — | — | EP | disclosed |
| WO-2017167832-A1 | BICYCLIC COMPOUNDS | BASF SE (DE) | 2017-10-05 | — | — | WO | disclosed |
| US-20150322070-A1 | PIPERIDINE INHIBITORS OF JANUS KINASE 3 | AUSPEX PHARMACEUTICALS, INC. | 2015-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150322070-A1 | PIPERIDINE INHIBITORS OF JANUS KINASE 3 | JAK2, JAK3, PAK3 | AOC3 1778/4885 |
| US-20190104738-A1 | BICYCLIC COMPOUNDS | CYP1B1, CYCS, CYP11B2 | AOC3 245/4885 |
| US-11570992-B2 | Bicyclic compounds | CYP1B1, CYCS, CYP11B2 | AOC3 245/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.